Prenatal Bone Development

Pediatric Bone

Volumn , Issue , 2012, Pages 39-53

  Long, Fanxin ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84872015978     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-12-382040-2.10003-6     Document Type: Chapter

References (176)

1. Carroll R.L. Vertebrate Paleontology and Evolution 1988, Freeman, New York.
2. Patterson C. Cartilage bones, dermal bones, and membrane bones, or the exoskeleton versus the endoskeleton. Problems in Vertebrate Evolution 1977, 77-121. Academic Press, London. S. Andrews, R. Miles, A. Walker (Eds.).
3. Gardner E. Osteogenesis in the human embryo and fetus. The Biochemistry and Physiology of Bone 1971, 77-118. Academic Press, New York. G.H. Bourne (Ed.).
4. Thompson T.J., Owens P.D., Wilson D.J. Intramembranous osteogenesis and angiogenesis in the chick embryo. J Anat 1989, 166:55-65.
5. Pritchard J.J. General histology of bone. The Biochemistry and Physiology of Bone 1972, 1-20. Academic Press, New York. G.H. Bourne (Ed.).
6. Thorogood P.V., Hinchliffe J.R. An analysis of the condensation process during chondrogenesis in the embryonic chick hind limb. J Embryol Exp Morphol 1975, 33:581-606.
7. Ede D.A. Cellular condensations and chondrogenesis. Cartilage Development, Differentiation and Growth 1983, 143-185. Academic Press, New York. B.K. Hall (Ed.).
8. Caplan A.I., Pechak D.G. The cellular and molecular embryology of bone formation. Bone and Mineral Research 1987, 117-183. Elsevier, New York. W.A. Peck (Ed.).
9. Poole A.R. The growth plate: Cellular physiology, cartilage assembly and mineralization. Cartilage: Molecular Aspects 1991, 179-211. CRC Press, Boca Raton. B.K. Hall (Ed.).
10. Vu T.H., Shipley J.M., Bergers G., et al. MMP-9/gelatinase B is a key regulator of growth plate angiogenesis and apoptosis of hypertrophic chondrocytes. Cell 1998, 93:411-422.
11. Sadler T.W. Longman's Medical Embryology 2000, Lippincott Williams & Wilkins, Philadelphia.
12. Lemire R.J. Embryology of the skull. Craniosynostosis: Diagnosis, Evaluation, and Management 2000, 24-34. Oxford University Press, Oxford. M.M. Cohen, R.E. MacLean (Eds.).
13. Noback C.R., Robertson G.G. Sequences of appearance of ossification centers in the human skeleton during the first five prenatal months. Am J Anat 1951, 89:1-28.
14. Dixon A.D. Prenatal development of the facial skeleton. Fundamentals of Craniofacial Growth 1997, 59-97. CRC Press, Boca Raton. A.D. Dixon, D.A.N. Hoyte, O. Ronning (Eds.).
15. Carlson B.M. Human Embryology and Developmental Biology 1999, Mosby, St Louis.
16. Hall B.K. Embryonic bone formation with special reference to epithelial-mesenchymal interactions and growth factors. Bone: Mechanisms of Bone Development and Growth 1994, 137-192. CRC Press, Boca Raton. B.K. Hall (Ed.).
17. Tissue interactions and chondrogenesis. Cartilage; Development, Differentiation, and Growth 1983, 187-222. Academic Press, New York. B.K. Hall (Ed.).
18. Thorogood P. Morphogenesis of cartilage. Cartilage: Development, Differentiation, and Growth 1983, 223-254. Academic Press, New York. B.K. Hall (Ed.).
19. Kawabata M., Miyazomo K. Bone morphogenic proteins. Skeletal Growth Factors 2000, 269-290. Lippincott Williams & Wilkins, Philadelphia. E. Canalis (Ed.).
20. Sampath T.K., Reddi A.H. Dissociative extraction and reconstitution of extracellular matrix components involved in local bone differentiation. Proc Natl Acad Sci USA 1981, 78:7599-7603.
21. Urist M.R., Mikulski A., Lietze A. Solubilized and insolubilized bone morphogenetic protein. Proc Natl Acad Sci USA 1979, 76:1828-1832.
22. Rosen V., Cox K., Hattersley G. Bone morphogenic proteins. Principles of Bone Biology 1996, 661-671. Academic Press, New York. J.P. Bilezikian, L.G. Raisz, G.A. Rodan (Eds.).
23. Reddi A.H. Role of morphogenetic proteins in skeletal tissue engineering and regeneration. Nat Biotechnol 1998, 16:247-252.
24. Karsenty G., Wagner E.F. Reaching a genetic and molecular understanding of skeletal development. Dev Cell 2002, 2:389-406.
25. Paralkar V.M., Nandedkar A.K., Pointer R.H., Kleinman H.K., Reddi A.H. Interaction of osteogenin, a heparin binding bone morphogenetic protein, with type IV collagen. J Biol Chem 1990, 265:17281-17284.
26. Zhu Y., Oganesian A., Keene D.R., Sandell L.J. Type IIA procollagen containing the cysteine-rich amino propeptide is deposited in the extracellular matrix of prechondrogenic tissue and binds to TGF-beta1 and BMP-2. J Cell Biol 1999, 144:1069-1080.
27. Satokata I., Maas R. Msx1 deficient mice exhibit cleft palate and abnormalities of craniofacial and tooth development. Nat Genet 1994, 6:348-356.
28. Takahashi Y., Bontoux M., Le Douarin N.M. Epithelio-mesenchymal interactions are critical for Quox 7 expression and membrane bone differentiation in the neural crest derived mandibular mesenchyme. Embo J 1991, 10:2387-2393.
29. Barlow A.J., Francis-West P.H. Ectopic application of recombinant BMP-2 and BMP-4 can change patterning of developing chick facial primordia. Development 1997, 124:391-398.
30. Hall B.K., Miyake T. All for one and one for all: condensations and the initiation of skeletal development. Bioessays 2000, 22:138-147.
31. Coelho C.N., Kosher R.A. Gap junctional communication during limb cartilage differentiation. Dev Biol 1991, 144:47-53.
32. Zimmermann B. Assembly and disassembly of gap junctions during mesenchymal cell condensation and early chondrogenesis in limb buds of mouse embryos. J Anat 1984, 138:351-363.
33. DeLise A.M., Fischer L., Tuan R.S. Cellular interactions and signaling in cartilage development. Osteoarthr Cart 2000, 8:309-334.
34. Haas A.R., Tuan R.S. Chondrogenic differentiation of murine C3H10T1/2 multipotential mesenchymal cells: II. Stimulation by bone morphogenetic protein-2 requires modulation of N-cadherin expression and function. Differentiation 1999, 64:77-89.
35. Widelitz R.B., Jiang T.X., Murray B.A., Chuong C.M. Adhesion molecules in skeletogenesis: II. Neural cell adhesion molecules mediate precartilaginous mesenchymal condensations and enhance chondrogenesis. J Cell Physiol 1993, 156:399-411.
36. Flanagan J.G., Vanderhaeghen P. The ephrins and Eph receptors in neural development. Annu Rev Neurosci 1998, 21:309-345.
37. Davy A., Bush J.O., Soriano P. Inhibition of gap junction communication at ectopic Eph/ephrin boundaries underlies craniofrontonasal syndrome. PLoS Biol 2006, 4:e315.
38. Stadler H.S., Higgins K.M., Capecchi M.R. Loss of Eph-receptor expression correlates with loss of cell adhesion and chondrogenic capacity in Hoxa13 mutant limbs. Development 2001, 128:4177-4188.
39. Wada N., Kimura I., Tanaka H., Ide H., Nohno T. Glycosylphosphatidylinositol-anchored cell surface proteins regulate position-specific cell affinity in the limb bud. Dev Biol 1998, 202:244-252.
40. Goff D.J., Tabin C.J. Analysis of Hoxd-13 and Hoxd-11 misexpression in chick limb buds reveals that Hox genes affect both bone condensation and growth. Development 1997, 124:627-636.
41. Yokouchi Y., Nakazato S., Yamamoto M., et al. Misexpression of Hoxa-13 induces cartilage homeotic transformation and changes cell adhesiveness in chick limb buds. Genes Dev 1995, 9:2509-2522.
42. Knudson C.B., Toole B.P. Hyaluronate-cell interactions during differentiation of chick embryo limb mesoderm. Dev Biol 1987, 124:82-90.
43. Toole B.P., Jackson G., Gross J. Hyaluronate in morphogenesis: inhibition of chondrogenesis in vitro. Proc Natl Acad Sci USA 1972, 69:1384-1386.
44. Kosher R.A. Syndecan-3 in limb skeletal development. Microsc Res Tech 1998, 43:123-130.
45. Seghatoleslami M.R., Kosher R.A. Inhibition of in vitro limb cartilage differentiation by syndecan-3 antibodies. Dev Dyn 1996, 207:114-119.
46. Kulyk W.M., Upholt W.B., Kosher R.A. Fibronectin gene expression during limb cartilage differentiation. Development 1989, 106:449-455.
47. Frenz D.A., Akiyama S.K., Paulsen D.F., Newman S.A. Latex beads as probes of cell surface-extracellular matrix interactions during chondrogenesis: evidence for a role for amino-terminal heparin-binding domain of fibronectin. Dev Biol 1989, 136:87-96.
48. Frenz D.A., Jaikaria N.S., Newman S.A. The mechanism of precartilage mesenchymal condensation: a major role for interaction of the cell surface with the amino-terminal heparin-binding domain of fibronectin. Dev Biol 1989, 136:97-103.
49. Gehris A.L., Stringa E., Spina J., Desmond M.E., Tuan R.S., Bennett V.D. The region encoded by the alternatively spliced exon IIIA in mesenchymal fibronectin appears essential for chondrogenesis at the level of cellular condensation. Dev Biol 1997, 190:191-205.
50. Chimal-Monroy J., Diaz de Leon L. Expression of N-cadherin, N-CAM, fibronectin and tenascin is stimulated by TGF-beta1, beta2, beta3 and beta5 during the formation of precartilage condensations. Int J Dev Biol 1999, 43:59-67.
51. Leonard C.M., Fuld H.M., Frenz D.A., Downie S.A., Massague J., Newman S.A. Role of transforming growth factor-beta in chondrogenic pattern formation in the embryonic limb: stimulation of mesenchymal condensation and fibronectin gene expression by exogenenous TGF-beta and evidence for endogenous TGF-beta-like activity. Dev Biol 1991, 145:99-109.
52. Francis-West P.H., Abdelfattah A., Chen P., et al. Mechanisms of GDF-5 action during skeletal development. Development 1999, 126:1305-1315.
53. Zou H., Wieser R., Massague J., Niswander L. Distinct roles of type I bone morphogenetic protein receptors in the formation and differentiation of cartilage. Genes Dev 1997, 11:2191-2203.
54. Tsumaki N., Nakase T., Miyaji T., et al. Bone morphogenetic protein signals are required for cartilage formation and differently regulate joint development during skeletogenesis. J Bone Miner Res 2002, 17:898-906.
55. Tsumaki N., Tanaka K., Arikawa-Hirasawa E., et al. Role of CDMP-1 in skeletal morphogenesis: promotion of mesenchymal cell recruitment and chondrocyte differentiation. J Cell Biol 1999, 144:161-173.
56. Merino R., Ganan Y., Macias D., Economides A.N., Sampath K.T., Hurle J.M. Morphogenesis of digits in the avian limb is controlled by FGFs, TGFbetas, and noggin through BMP signaling. Dev Biol 1998, 200:35-45.
57. Mishina Y., Suzuki A., Ueno N., Behringer R.R. Bmpr encodes a type I bone morphogenetic protein receptor that is essential for gastrulation during mouse embryogenesis. Genes Dev 1995, 9:3027-3037.
58. Winnier G., Blessing M., Labosky P.A., Hogan B.L. Bone morphogenetic protein-4 is required for mesoderm formation and patterning in the mouse. Genes Dev 1995, 9:2105-2116.
59. Zhang H., Bradley A. Mice deficient for BMP2 are nonviable and have defects in amnion/chorion and cardiac development. Development 1996, 122:2977-2986.
60. Daluiski A., Engstrand T., Bahamonde M.E., et al. Bone morphogenetic protein-3 is a negative regulator of bone density. Nat Genet 2001, 27:84-88.
61. Zhao R., Lawler A.M., Lee S.J. Characterization of GDF-10 expression patterns and null mice. Dev Biol 1999, 212:68-79.
62. Bandyopadhyay A., Tsuji K., Cox K., Harfe B.D., Rosen V., Tabin C.J. Genetic analysis of the roles of BMP2, BMP4, and BMP7 in limb patterning and skeletogenesis. PLoS Genet 2006, 2:e216.
63. Luyten F.P., Kaplan F.S., Shore E.M. Clinical disorders associated with bone morphogenic proteins. Skeletal Growth Factors 2000, 323-334. Lippincott Williams & Wilkins, Philadelphia. E. Canalis (Ed.).
64. Gong Y., Krakow D., Marcelino J., et al. Heterozygous mutations in the gene encoding noggin affect human joint morphogenesis. Nat Genet 1999, 21:302-304.
65. Brunet L.J., McMahon J.A., McMahon A.P., Harland R.M. Noggin, cartilage morphogenesis, and joint formation in the mammalian skeleton. Science 1998, 280:1455-1457.
66. Pizette S., Niswander L. BMPs are required at two steps of limb chondrogenesis: formation of prechondrogenic condensations and their differentiation into chondrocytes. Dev Biol 2000, 219:237-249.
67. Weston A.D., Rosen V., Chandraratna R.A., Underhill T.M. Regulation of skeletal progenitor differentiation by the BMP and retinoid signaling pathways. J Cell Biol 2000, 148:679-690.
68. Barna M., Niswander L. Visualization of cartilage formation: insight into cellular properties of skeletal progenitors and chondrodysplasia syndromes. Dev Cell 2007, 12:931-941.
69. Eshkar-Oren I., Viukov S.V., Salameh S., et al. The forming limb skeleton serves as a signaling center for limb vasculature patterning via regulation of Vegf. Development 2009, 136:1263-1272.
70. Foster J.W., Dominguez-Steglich M.A., Guioli S., et al. Campomelic dysplasia and autosomal sex reversal caused by mutations in an SRY-related gene. Nature 1994, 372:525-530.
71. Bi W., Deng J.M., Zhang Z., Behringer R.R., de Crombrugghe B. Sox9 is required for cartilage formation. Nat Genet 1999, 22:85-89.
72. Mori-Akiyama Y., Akiyama H., Rowitch D.H., de Crombrugghe B. Sox9 is required for determination of the chondrogenic cell lineage in the cranial neural crest. Proc Natl Acad Sci USA 2003, 100:9360-9365.
73. Smits P., Li P., Mandel J., et al. The transcription factors L-Sox5 and Sox6 are essential for cartilage formation. Dev Cell 2001, 1:277-290.
74. Massague J., Seoane J., Wotton D. Smad transcription factors. Genes Dev 2005, 19:2783-2810.
75. Yoon B.S., Ovchinnikov D.A., Yoshii I., Mishina Y., Behringer R.R., Lyons K.M. Bmpr1a and Bmpr1b have overlapping functions and are essential for chondrogenesis in vivo. Proc Natl Acad Sci USA 2005, 102:5062-5067.
76. Retting K.N., Song B., Yoon B.S., Lyons K.M. BMP canonical Smad signaling through Smad1 and Smad5 is required for endochondral bone formation. Development 2009, 136:1093-1104.
77. Zhang J., Tan X., Li W., et al. Smad4 is required for the normal organization of the cartilage growth plate. Dev Biol 2005, 284:311-322.
78. Liu F., Pouponno C., Massague J. Dual role of the Smad4/DPC4 tumor suppressor in TGFbeta-inducible transcriptional complexes. Genes Dev 1997, 11:3157-3167.
79. Wodarz A., Nusse R. Mechanisms of Wnt signaling in development. Annu Rev Cell Dev Biol 1998, 14:59-88.
80. Wu X., Tu X., Joeng K.S., Hilton M.J., Williams D.A., Long F. Rac1 activation controls nuclear localization of beta-catenin during canonical Wnt signaling. Cell 2008, 133:340-353.
81. Rudnicki J.A., Brown A.M. Inhibition of chondrogenesis by Wnt gene expression in vivo and in vitro. Dev Biol 1997, 185:104-118.
82. Stott N.S., Jiang T.X., Chuong C.M. Successive formative stages of precartilaginous mesenchymal condensations in vitro: modulation of cell adhesion by Wnt-7A and BMP-2. J Cell Physiol 1999, 180:314-324.
83. Hill T.P., Spater D., Taketo M.M., Birchmeier W., Hartmann C. Canonical Wnt/beta-catenin signaling prevents osteoblasts from differentiating into chondrocytes. Dev Cell 2005, 8:727-738.
84. Akiyama H., Lyons J.P., Mori-Akiyama Y., et al. Interactions between Sox9 and beta-catenin control chondrocyte differentiation. Genes Dev 2004, 18:1072-1087.
85. Artavanis-Tsakonas S., Rand M.D., Lake R.J. Notch signaling: cell fate control and signal integration in development. Science 1999, 284:770-776.
86. Chiba S. Notch signaling in stem cell systems. Stem Cells 2006, 24:2437-2447.
87. Kopan R., Goate A. A common enzyme connects notch signaling and Alzheimer's disease. Genes Dev 2000, 14:2799-2806.
88. Kopan R., Ilagan M.X. The canonical Notch signaling pathway: unfolding the activation mechanism. Cell 2009, 137:216-233.
89. Schroeter E.H., Kisslinger J.A., Kopan R. Notch-1 signalling requires ligand-induced proteolytic release of intracellular domain. Nature 1998, 393:382-386.
90. Honjo T. The shortest path from the surface to the nucleus: RBP-J kappa/Su(H) transcription factor. Genes Cells 1996, 1:1-9.
91. Dong Y., Jesse A.M., Kohn A., et al. RBPjkappa-dependent Notch signaling regulates mesenchymal progenitor cell proliferation and differentiation during skeletal development. Development 2010, 137:1461-1471.
92. Dunwoodie S.L., Clements M., Sparrow D.B., Sa X., Conlon R.A., Beddington R.S. Axial skeletal defects caused by mutation in the spondylocostal dysplasia/pudgy gene Dll3 are associated with disruption of the segmentation clock within the presomitic mesoderm. Development 2002, 129:1795-1806.
93. Shen J., Bronson R.T., Chen D.F., Xia W., Selkoe D.J., Tonegawa S. Skeletal and CNS defects in Presenilin-1-deficient mice. Cell 1997, 89:629-639.
94. Wong P.C., Zheng H., Chen H., et al. Presenilin 1 is required for Notch1 and DII1 expression in the paraxial mesoderm. Nature 1997, 387:288-292.
95. Zhang N., Gridley T. Defects in somite formation in lunatic fringe-deficient mice. Nature 1998, 394:374-377.
96. Bulman M.P., Kusumi K., Frayling T.M., et al. Mutations in the human delta homologue, DLL3, cause axial skeletal defects in spondylocostal dysostosis. Nat Genet 2000, 24:438-441.
97. Cash D.E., Bock C.B., Schughart K., Linney E., Underhill T.M. Retinoic acid receptor alpha function in vertebrate limb skeletogenesis: a modulator of chondrogenesis. J Cell Biol 1997, 136:445-457.
98. Semba I., Nonaka K., Takahashi I., et al. Positionally-dependent chondrogenesis induced by BMP4 is co-regulated by Sox9 and Msx2. Dev Dyn 2000, 217:401-414.
99. Takahashi K., Nuckolls G.H., Takahashi I., et al. Msx2 is a repressor of chondrogenic differentiation in migratory cranial neural crest cells. Dev Dyn 2001, 222:252-262.
100. Lee K., Deeds J.D., Segre G.V. Expression of parathyroid hormone-related peptide and its receptor messenger ribonucleic acids during fetal development of rats. Endocrinology 1995, 136:453-463.
101. St-Jacques B., Hammerschmidt M., McMahon A.P. Indian hedgehog signaling regulates proliferation and differentiation of chondrocytes and is essential for bone formation. Genes Dev 1999, 13:2072-2086.
102. Vortkamp A., Lee K., Lanske B., Segre G.V., Kronenberg H.M., Tabin C.J. Regulation of rate of cartilage differentiation by Indian hedgehog and PTH-related protein. Science 1996, 273:613-622.
103. Karaplis A.C., Luz A., Glowacki J., et al. Lethal skeletal dysplasia from targeted disruption of the parathyroid hormone-related peptide gene. Genes Dev 1994, 8:277-289.
104. Chung U.I., Lanske B., Lee K., Li E., Kronenberg H. The parathyroid hormone/parathyroid hormone-related peptide receptor coordinates endochondral bone development by directly controlling chondrocyte differentiation. Proc Natl Acad Sci USA 1998, 95:13030-13035.
105. Guo J., Chung U.I., Kondo H., Bringhurst F.R., Kronenberg H.M. The PTH/PTHrP receptor can delay chondrocyte hypertrophy in vivo without activating phospholipase C. Dev Cell 2002, 3:183-194.
106. Huang W., Chung U.I., Kronenberg H.M., de Crombrugghe B. The chondrogenic transcription factor Sox9 is a target of signaling by the parathyroid hormone-related peptide in the growth plate of endochondral bones. Proc Natl Acad Sci USA 2001, 98:160-165.
107. Weir E.C., Philbrick W.M., Amling M., Neff L.A., Baron R., Broadus A.E. Targeted overexpression of parathyroid hormone-related peptide in chondrocytes causes chondrodysplasia and delayed endochondral bone formation. Proc Natl Acad Sci USA 1996, 93:10240-10245.
108. Jobert A.S., Zhang P., Couvineau A., et al. Absence of functional receptors for parathyroid hormone and parathyroid hormone-related peptide in Blomstrand chondrodysplasia. J Clin Invest 1998, 102:34-40.
109. Karaplis A.C., He B., Nguyen M.T., et al. Inactivating mutation in the human parathyroid hormone receptor type 1 gene in Blomstrand chondrodysplasia. Endocrinology 1998, 139:5255-5258.
110. Karperien M., van der Harten H.J., van Schooten R., et al. A frame-shift mutation in the type I parathyroid hormone (PTH)/PTH-related peptide receptor causing Blomstrand lethal osteochondrodysplasia. J Clin Endocrinol Metab 1999, 84:3713-3720.
111. Schipani E., Kruse K., Juppner H. A constitutively active mutant PTH-PTHrP receptor in Jansen-type metaphyseal chondrodysplasia. Science 1995, 268:98-100.
112. Schipani E., Langman C.B., Parfitt A.M., et al. Constitutively activated receptors for parathyroid hormone and parathyroid hormone-related peptide in Jansen's metaphyseal chondrodysplasia. N Engl J Med 1996, 335:708-714.
113. Schipani E., Lanske B., Hunzelman J., et al. Targeted expression of constitutively active receptors for parathyroid hormone and parathyroid hormone-related peptide delays endochondral bone formation and rescues mice that lack parathyroid hormone-related peptide. Proc Natl Acad Sci USA 1997, 94:13689-13694.
114. Hopyan S., Gokgoz N., Poon R., et al. A mutant PTH/PTHrP type I receptor in enchondromatosis. Nat Genet 2002, 30:306-310.
115. Rozeman L.B., Sansgiorgi L., Inge H., et al. Enchondromatosis (Ollier disease, Maffucci syndrome) is not caused by the PTHR1 mutation p.R150C. Hum Mutat 2004, 24:466-473.
116. Couvineau A., Wouters V., Bertand G., et al. PTHR1 mutations associated with Ollier disease result in receptor loss of function. Hum Molec Genet 2008, 17:2766-2775.
117. Huangfu D., Anderson K.V. Signaling from Smo to Ci/Gli: conservation and divergence of Hedgehog pathways from Drosophila to vertebrates. Development 2006, 133:3-14.
118. Ingham P.W., McMahon A.P. Hedgehog signaling in animal development: paradigms and principles. Genes Dev 2001, 15:3059-3087.
119. McMahon A.P., Ingham P.W., Tabin C.J. Developmental roles and clinical significance of hedgehog signaling. Curr Top Dev Biol 2003, 53:1-114.
120. Long F., Zhang X.M., Karp S., Yang Y., McMahon A.P. Genetic manipulation of hedgehog signaling in the endochondral skeleton reveals a direct role in the regulation of chondrocyte proliferation. Development 2001, 128:5099-6108.
121. Long F., Chung U.I., Ohba S., McMahon J., Kronenberg H.M., McMahon A.P. Ihh signaling is directly required for the osteoblast lineage in the endochondral skeleton. Development 2004, 131:1309-1318.
122. Karp S.J., Schipani E., St-Jacques B., Hunzelman J., Kronenberg H., McMahon A.P. Indian hedgehog coordinates endochondral bone growth and morphogenesis via parathyroid hormone related-protein-dependent and -independent pathways. Development 2000, 127:543-548.
123. Hilton MJ, Tu X, Long F. Tamixofen-inducible gene deletion reveals a distinct population of osteoblast-lineage cells, and direct regulation of PTHrP expression and chondrocyte morphology by Ihh. 2006;Submitted.
124. Kobayashi T., Soegiarto D.W., Yang Y., et al. Indian hedgehog stimulates periarticular chondrocyte differentiation to regulate growth plate length independently of PTHrP. J Clin Invest 2005, 115:1734-1742.
125. Hilton M.J., Tu X., Cook J., Hu H., Long F. Ihh controls cartilage development by antagonizing Gli3, but requires additional effectors to regulate osteoblast and vascular development. Development 2005, 132:4339-4351.
126. Koziel L., Wuelling M., Schneider S., Vortkamp A. Gli3 acts as a repressor downstream of Ihh in regulating two distinct steps of chondrocyte differentiation. Development 2005, 132:5249-5260.
127. Clemmons D.R. Insulin-like growth factors. Skeletal Growth Factors 2000, 79-99. Lippincott Williams & Wilkins, Philadelphia. E. Canalis (Ed.).
128. Baker J., Liu J.P., Robertson E.J., Efstratiadis A. Role of insulin-like growth factors in embryonic and postnatal growth. Cell 1993, 75:73-82.
129. DeChiara T.M., Efstratiadis A., Robertson E.J. A growth-deficiency phenotype in heterozygous mice carrying an insulin-like growth factor II gene disrupted by targeting. Nature 1990, 345:78-80.
130. Liu J.P., Baker J., Perkins A.S., Robertson E.J., Efstratiadis A. Mice carrying null mutations of the genes encoding insulin-like growth factor I (Igf-1) and type 1 IGF receptor (Igf1r). Cell 1993, 75:59-72.
131. Long F., Joeng K.S., Xuan S., Efstratiadis A., McMahon A.P. Independent regulation of skeletal growth by Ihh and IGF signaling. Dev Biol 2006, 298:327-333.
132. Ornitz D.M., Marie P.J. FGF signaling pathways in endochondral and intramembranous bone development and human genetic disease. Genes Dev 2002, 16:1446-1465.
133. Itoh N., Ornitz D.M. Functional evolutionary history of the mouse Fgf gene family. Dev Dyn 2008, 237:18-27.
134. Eswarakumar V.P., Lax I., Schlessinger J. Cellular signaling by fibroblast growth factor receptors. Cytokine Growth Factor Rev 2005, 16:139-149.
135. Rousseau F., Bonaventure J., Legeai-Mallet L., et al. Mutations in the gene encoding fibroblast growth factor receptor-3 in achondroplasia. Nature 1994, 371:252-254.
136. Shiang R., Thompson L.M., Zhu Y.Z., et al. Mutations in the transmembrane domain of FGFR3 cause the most common genetic form of dwarfism, achondroplasia. Cell 1994, 78:335-342.
137. Chen L., Adar R., Yang X., et al. Gly369Cys mutation in mouse FGFR3 causes achondroplasia by affecting both chondrogenesis and osteogenesis. J Clin Invest 1999, 104:1517-1525.
138. Naski M.C., Colvin J.S., Coffin J.D., Ornitz D.M. Repression of hedgehog signaling and BMP4 expression in growth plate cartilage by fibroblast growth factor receptor 3. Development 1998, 125:4977-4988.
139. Colvin J.S., Bohne B.A., Harding G.W., McEwen D.G., Ornitz D.M. Skeletal overgrowth and deafness in mice lacking fibroblast growth factor receptor 3. Nat Genet 1996, 12:390-397.
140. Deng C., Wynshaw-Boris A., Zhou F., Kuo A., Leder P. Fibroblast growth factor receptor 3 is a negative regulator of bone growth. Cell 1996, 84:911-921.
141. Liu Z., Xu J., Colvin J.S., Ornitz D.M. Coordination of chondrogenesis and osteogenesis by fibroblast growth factor 18. Genes Dev 2002, 16:859-869.
142. Ohbayashi N., Shibayama M., Kurotaki Y., et al. FGF18 is required for normal cell proliferation and differentiation during osteogenesis and chondrogenesis. Genes Dev 2002, 16:870-879.
143. Sahni M., Ambrosetti D.C., Mansukhani A., Gertner R., Levy D., Basilico C. FGF signaling inhibits chondrocyte proliferation and regulates bone development through the STAT-1 pathway. Genes Dev 1999, 13:1361-1366.
144. Su W.C., Kitagawa M., Xue N., et al. Activation of Stat1 by mutant fibroblast growth-factor receptor in thanatophoric dysplasia type II dwarfism. Nature 1997, 386:288-292.
145. Murakami S., Kan M., McKeehan W.L., de Crombrugghe B. Up-regulation of the chondrogenic Sox9 gene by fibroblast growth factors is mediated by the mitogen-activated protein kinase pathway. Proc Natl Acad Sci USA 2000, 97:1113-1118.
146. Komori T., Yagi H., Nomura S., et al. Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts. Cell 1997, 89:755-764.
147. Otto F., Thornell A.P., Crompton T., et al. Cbfa1, a candidate gene for cleidocranial dysplasia syndrome, is essential for osteoblast differentiation and bone development. Cell 1997, 89:765-771.
148. Ducy P., Starbuck M., Priemel M., et al. A Cbfa1-dependent genetic pathway controls bone formation beyond embryonic development. Genes Dev 1999, 13:1025-1036.
149. Stricker S., Fundele R., Vortkamp A., Mundlos S. Role of Runx genes in chondrocyte differentiation. Dev Biol 2002, 245:95-108.
150. Liu W., Toyosawa S., Furuichi T., et al. Overexpression of Cbfa1 in osteoblasts inhibits osteoblast maturation and causes osteopenia with multiple fractures. J Cell Biol 2001, 155:157-166.
151. Mundlos S., Otto F., Mundlos C., et al. Mutations involving the transcription factor CBFA1 cause cleidocranial dysplasia. Cell 1997, 89:773-779.
152. Nakashima K., Zhou X., Kunkel G., et al. The novel zinc finger-containing transcription factor osterix is required for osteoblast differentiation and bone formation. Cell 2002, 108:17-29.
153. Yang X., Matsuda K., Bialek P., et al. ATF4 is a substrate of RSK2 and an essential regulator of osteoblast biology; implication for Coffin-Lowry Syndrome. Cell 2004, 117:387-398.
154. Long F. Targeting intercellular signals for bone regeneration from bone marrow mesenchymal progenitors. Cell Cycle 2008, 7:2106-2111.
155. Hu H., Hilton M.J., Tu X., Yu K., Ornitz D.M. Long, F. Sequential roles of Hedgehog and Wnt signaling in osteoblast development. Development 2005, 132:49-60.
156. Hilton M.J., Tu X., Wu X., et al. Notch signaling maintains bone marrow mesenchymal progenitors by suppressing osteoblast differentiation. Nat Med 2008, 14:306-314.
157. Joeng K.S., Long F. The Gli2 transcriptional activator is a crucial effector for Ihh signaling in osteoblast development and cartilage vascularization. Development 2009, 136:4177-4185.
158. Miao D., Liu H., Plut P., et al. Impaired endochondral bone development and osteopenia in Gli2-deficient mice. Exp Cell Res 2004, 294:210-222.
159. Day T.F., Guo X., Garrett-Beal L., Yang Y. Wnt/beta-catenin signaling in mesenchymal progenitors controls osteoblast and chondrocyte differentiation during vertebrate skeletogenesis. Dev Cell 2005, 8:739-750.
160. Rodda S.J., McMahon A.P. Distinct roles for Hedgehog and canonical Wnt signaling in specification, differentiation and maintenance of osteoblast progenitors. Development 2006, 133:3231-3244.
161. Glass D.A., Bialek P., Ahn J.D., et al. Canonical Wnt signaling in differentiated osteoblasts controls osteoclast differentiation. Dev Cell 2005, 8:751-764.
162. Holmen S.L., Zylstra C.R., Mukherjee A., et al. Essential role of beta-catenin in postnatal bone acquisition. J Biol Chem 2005, 280:21162-21168.
163. Takada I., Mihara M., Suzawa M., et al. A histone lysine methyltransferase activated by non-canonical Wnt signalling suppresses PPAR-gamma transactivation. Nat Cell Biol 2007, 9:1273-1285.
164. Tu X., Joeng K.S., Nakayama K.I., et al. Noncanonical Wnt signaling through G protein-linked PKCdelta activation promotes bone formation. Dev Cell 2007, 12:113-127.
165. Mishina Y., Starbuck M.W., Gentile M.A., et al. Bone morphogenetic protein type IA receptor signaling regulates postnatal osteoblast function and bone remodeling. J Biol Chem 2004, 279:27560-27566.
166. Devlin R.D., Du Z., Pereira R.C., et al. Skeletal overexpression of noggin results in osteopenia and reduced bone formation. Endocrinology 2003, 144:1972-1978.
167. Eswarakumar V.P., Monsonego-Ornan E., Pines M., Antonopoulou I., Morriss-Kay G.M., Lonai P. The IIIc alternative of Fgfr2 is a positive regulator of bone formation. Development 2002, 129:3783-3793.
168. Eswarakumar V.P., Horowitz M.C., Locklin R., Morriss-Kay G.M., Lonai P. A gain-of-function mutation of Fgfr2c demonstrates the roles of this receptor variant in osteogenesis. Proc Natl Acad Sci USA 2004, 101:12555-12560.
169. Zhou Y.X., Xu X., Chen L., Li C., Brodie S.G., Deng C.X. A Pro250Arg substitution in mouse Fgfr1 causes increased expression of Cbfa1 and premature fusion of calvarial sutures. Hum Mol Genet 2000, 9:2001-2008.
170. Jacob A.L., Smith C., Partanen J., Ornitz D.M. Fibroblast growth factor receptor 1 signaling in the osteo-chondrogenic cell lineage regulates sequential steps of osteoblast maturation. Dev Biol 2006, 296:315-328.
171. Valverde-Franco G., Liu H., Davidson D., et al. Defective bone mineralization and osteopenia in young adult FGFR3-/- mice. Hum Mol Genet 2004, 13:271-284.
172. Zanotti S., Smerdel-Ramoya A., Stadmeyer L., Durant D., Radtke F., Canalis E. Notch inhibits osteoblast differentiation and causes osteopenia. Endocrinology 2008, 149:3890-3899.
173. Engin F., Yao Z., Yang T., et al. Dimorphic effects of Notch signaling in bone homeostasis. Nat Med 2008, 14:299-305.
174. Tao J., Chen S., Yang T., et al. Osteosclerosis owing to Notch gain of function is solely Rbpj-dependent. J Bone Miner Res 2010, 25:2175-2183.
175. Garg V., Muth A.N., Ransom J.F., et al. Mutations in NOTCH1 cause aortic valve disease. Nature 2005, 437:270-274.
176. Mohamed S.A., Aherrahrou Z., Liptau H., et al. Novel missense mutations (p.T596M and p.P1797H) in NOTCH1 in patients with bicuspid aortic valve. Biochem Biophys Res Commun 2006, 345:1460-1465.